NCT01020734View on ClinicalTrials.gov

Donor Stem Cell Transplant or Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia in Remission

PHASE2CompletedINTERVENTIONAL
Enrollment

263

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Leukemia
Interventions
BIOLOGICAL

anti-thymocyte globulin

DRUG

busulfan

DRUG

cyclophosphamide

DRUG

cyclosporine

DRUG

fludarabine phosphate

DRUG

methotrexate

PROCEDURE

allogeneic hematopoietic stem cell transplantation

Trial Locations (2)

612-030

Inje University - Haeundae Paik Hospital, Busan

138-736

Asan Medical Center - University of Ulsan College of Medicine, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER